Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

North America Anchors Colgate As Currency Headwinds Continue Abroad

Executive Summary

Innovation across categories helped make Colgate's North American business its star segment in the second quarter, rising 1.6% to $793m on strong oral care sales, while the firm’s international business remains impacted negatively by currency headwinds.

You may also be interested in...



Colgate Total Proof UK Ad Gets Broadcasters' Help In Regulator’s Review

A Colgate Total Proof toothpaste UK TV ad did not falsely imply that an animated color change of the toothpaste is an indication of antibacterial capability but is an indicator of time spent brushing teeth, says the country's advertising regulator.

Colgate Mitigates Currency Crush Via Oral-Care Sales, Price Hikes

Price increases in some regions were critical to earnings in Colgate's second quarter, and will continue to be executed at the expense of volume as needed, while oral-care product launches also are helping to offset negative currency effects, the firm reported July 30. With an oral-care business that is “one of the few remaining category killers,” Colgate should consider divesting its home-care and pet-product businesses, an analyst suggests.

Colgate Deflects Currency Crush Through Oral Care Sales, Price Hikes

Price increases in some regions are crucial to its earnings while Colgate also looks to oral care product launches as sales drivers. With an oral care business that is “one of the few remaining category killers,” the firm could create more value by divesting its home care and pet product businesses, an analyst says.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS118866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel